T cell signaling: A decision of life and death

Human Immunology

Volumn 60, Issue 5, 1999, Pages 403-411

  Medema, Jan Paul ^a   Borst, Jannie ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Apoptosis; CD95; Signaling; T cell; TCR

Indexed keywords

CYTOKINE; FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; APOPTOSIS; CELL DEATH; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032745755     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00008-7     Document Type: Article

References (97)

1. Borst J, Brouns GS, de Vries E, Verschuren MC, Mason DY, van Dongen JJ: Antigen receptors on T and B lymphocytes: parallels in organization and function. Immunol Rev 132:49, 1993.
2. Weiss A: T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73:209, 1993.
3. Samelson LE, Phillips AF, Luong ET, Klausner RD, Pignata C, Prasad KV, Hallek M, Druker B: Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci USA 87:4358, 1990.
4. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossman SF: The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human lymphocytes-T. Proc Nat Acad USA 85:5190, 1988.
5. Ostergaard HL, Shackelford DA, Hurley TR, Johnson P, Hyman R, Sefton BM, Trowbridge IS: Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA 86:8959, 1989.
6. Shiroo M, Goff L, Biffen M, Shivnan E, Alexander D: CD45 tyrosine phosphatase-activated Fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx. EMBO J 11:4887, 1992.
7. Stone JD, Conroy LA, Byth KF, Hederer RA, Howlett S, Takemoto Y, Holmes N, Alexander DR: Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ, and ZAP-70. J Immunol 158:5773, 1997.
8. van Oers NS, Killeen N, Weiss A: Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 183:1053, 1996.
9. Chan AC, Iwashima M, Turck CW, Weiss A: ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71:649, 1992.
10. Cheng AM, Negishi I, Anderson SJ, Chan AC, Bolen J, Loh DY, Pawson T: The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling. Proc Natl Acad Sci USA, 94:9797, 1997.
11. Iwashima, M, Irving BA, van Oers NSC, Chan AC, Weiss A: Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263:1136, 1994.
12. Cantrell DA: T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14:259, 1996.
13. Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, Burakoff SJ: Interaction of She with the ζ chain of the T cell receptor upon T cell activation. Science 262:902, 1993.
14. McCormick F: Activators and effectors of ras p21 proteins. Curr Opin Genet Dev 4:71, 1994.
15. Rayter S, Woodrow M, Lucas SC, Cantrell D, Downward J: p21Ras mediates control of IL-2 gene promotor function in T cell activation. EMBO J 15:3923, 1996.
16. Davis RJ: Transcriptional regulation by MAP kinases. Mol Reprod Dev 42:459, 1995.
17. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE: LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83, 1998.
18. Berridge MJ: Inositol trisphosphate and calcium signaling. Nature 361:315, 1993.
19. Clipstone NA, Crabtree GR: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695, 1992.
20. Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, Rao A: Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271: 10884, 1996.
21. Szamel M, Resch K: T-cell antigen receptor-induced signal-transduction pathways-activation and function of protein kinases C in T lymphocytes. Eur J Biochem 228:1, 1995.
22. Genot EM, Parker PJ, Cantrell DA: Analysis of the role of protein kinase C-alpha, -epsilon, and -zeta in T cell activation. J Biol Chem 270:9833, 1995.
23. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA: Stimulation of p21ras upon T-cell activation. Nature 346:719, 1990.
24. Tuosto L, Michel F, Acuto O: p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J Exp Med 184:1161, 1996.
25. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac1 GDP/ GTP exchange by the vav proto-oncogene product. Nature 385:169, 1997.
26. Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53, 1995.
27. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, Gutkind JS: Rac-1-dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13:455, 1996.
28. Wu J, Motto DG, Koretzky GA, Weiss A: Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593, 1996.
29. Fischer KD, Kong YY, Nishina H, Tedford K, Marengére LEM, Kozieradzki I, Sasaki T, Starr M, Chan G, Gardener S, Nghiem MP, Bouchard D, Barbacid M, Bernstein A, Penninger JM: Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol 8:554, 1998.
30. Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidson L, Lewis RS, Alt FW, Crabtree GR: Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 8:563, 1998.
31. Frearson JA, Yi T, Alexander DR: A tyrosine-phosphorylated 110-120kDa protein associates with the C-terminal SH2 domain of phosphotyrosine phosphatase-1D in T cell receptor-stimulated T cells. Eur J Immunol 26:1539, 1996.
32. Bos JL: A target for phosphoinositide 3-kinase: Akt/PKB. Trends Biochem Sci 20:441, 1995.
33. Jameson SC, Bevan MJ: T cell receptor antagonists and partial agonists. Immunity 2:1, 1995.
34. Sperling AI, Bluestone JA: The complexities of T-cell co-stimulation: CD28 and beyond. Immunol Rev 153: 155, 1996.
35. Lenschow DJ, Walumas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Ann Rev Immunol 14, 233, 1996.
36. August A, Dupont B: Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem Biophys Res Commun 199:1466, 1994.
37. August A, Gibson S, Kawakami Y, Kawakami T, Mills GB, Dupont B: CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci USA 91:9347, 1994.
38. Pages F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J, Olive D: Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369:327, 1994.
39. Schneider H, Cai YC, Prasad KV, Shoelson SE, Rudd CE: T cell antigen CD28 binds to GRB-2/SOS complex, regulators of p21ras. Eur J Immunol 25:1044, 1995.
40. Nunes J, Collette Y, Truneh A, Olive D, Cantrell DA: The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies not the ligand B7-1 activates p21ras. J Exp Med 180:1067, 1994.
41. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y: JNK is involved integration during costimulation of T lymphocytes. Cell 77:727, 1994.
42. Reif K, Cantrell DA: Networking rho family GTPase in lymphocytes. Immunity 8:395, 1998.
43. Civil A, Bakker A, Rensink I, Doerre S, Aarden LA, Verweij CL: Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. J Biol Chem 271:8321, 1996.
44. Shapiro VS, Truitt KE, Imboden JB, Weiss A: CD28 mediated transcriptional upregulation of the interleukin-2(IL-2) promotor through a composite element containing the CD28RE and NF-IL2B AP-1 sites. Mol Cell Biol 17:4051, 1997.
45. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4. Immunity 1:793, 1994.
46. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, Mak TW: Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1170, 1996.
47. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541, 1995.
48. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985, 1995.
49. Lanier LL: NK cell receptors. Annu Rev Immunol 16:359, 1998.
50. Frearson JA, Alexander DR: The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. Bioessays 19:417, 1997.
51. Smit L, Borst J: The Cbl family of signal transduction molecules. Critical Rev Oncogenesis 8:35, 1997.
52. Scharrenberg AM, Kinet JP: The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP. Cell 87:961, 1996.
53. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239, 1972.
54. Walczak H, Dhein J, Peter ME, Krammer PH: Activation-induced T cell death. Cell Death Differ 3:345, 1996.
55. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992.
56. Takahashi T, Tanaka M, Brannan, CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969, 1994.
57. Russell JH, White CL, Loh DY, Meleedy-Rey P: Receptor-stimulated death pathway is opened by antigen in mature T cells. PNAS 88:2151, 1991.
58. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of lpr/lpr mice have a defect in antigen-stimulated suicide. PNAS 90:4409, 1993.
59. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1/ (Fas/CD95). Nature 373:438, 1995.
60. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995.
61. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995.
62. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME: Cytotoxicity-dependent APO-1(Fas/CD95)-associated proteins form a death-inducing signalling complex (DISC) with the receptor. EMBO J 14:5579, 1995.
63. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795, 1995.
64. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995.
65. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803, 1996.
66. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Scaffidi C, Zhang M, Ni J, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a Novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex (DISC). Cell 85:817, 1996.
67. Scaffidi C, Medema JP, Krammer PH, Peter ME: FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272: 26953, 1997.
68. Henkart PA: ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195, 1996.
69. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794, 1997.
70. Muzio M, Salvesen GS, Dixit VM: FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem 272:2952, 1997.
71. Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 18:44, 1997.
72. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675, 1998.
73. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132, 1997.
74. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129, 1997.
75. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997.
76. Hannun YA: Functions of ceramide in coordinating cellular responses to stress. Science 274:1855, 1996.
77. Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ: Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 266:8531, 1991.
78. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W: Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95:3638, 1998.
79. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R: Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189, 1996.
80. De Maria R, Rippo MR, Schuchman EH, Testi R: Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med 187:897, 1998.
81. Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J: CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem 273:7560, 1998.
82. Tepper AD, Boesen-de Cock JGR, de Vries E, Borst J, van Blitterswijk WJ: CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem 272:24308, 1997.
83. Genestier L, Prigent AF, Paillot R, Quemeneur L, Durand I, Banchereau J, Revillard JP, Bonnefoy-Berard N: Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem 273:5060, 1998.
84. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993.
85. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH: FLICE is involved in regulation of activation-induced cell death (AICD) of peripheral T cells. Eur J Immunol 27:1207, 1997.
86. Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise LH, Thompson CB, Nuñez G: Bcl-xL is the major Bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120:3033, 1994.
87. Medema JP, Scaffidi C, Krammer PH, Peter ME: Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J Biol Chem 273: 3388, 1998.
88. Srinivasan A, Li F, Wong A, Kodandapani L, Smidt R Jr, Krebs JF, Fritz LC, Wu JC, Tomaselli KJ: Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem 273:4523, 1998.
89. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87, 1995.
90. Peter ME, Medema JP, Krammer PH: Does the Caenorhabditis Elegans protein CED-4 contain a region of homology to the mammalian death effector domain? Cell Death Differ 4:523, 1997.
91. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S: Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14:6136, 1995.
92. Petschner F, Zimmerman C, Strasser A, Grillot D, Nunez G, Pircher H: Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection. Eur J Immunol 28:560, 1998.
93. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517, 1997.
94. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI: Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 94:1172, 1997.
95. Hu S, Vincenz C, Buller M, Dixit VM: A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem 272:9621, 1997.
96. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 388:190, 1997.
97. Wallach D: Apoptosis. Placing death under control. Nature 388:123, 1997.